Shield Therapeutics Plc (STX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2015 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 1,074 |
| Other current assets | 142 |
| TOTAL | $3,452 |
| Non-Current Assets | |
| PPE Net | 25 |
| Intangibles | 760 |
| TOTAL | $785 |
| Total Assets | $4,237 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 1,797 |
| Other current liabilities | 108 |
| TOTAL | $5,296 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 26,560 |
| TOTAL | $26,560 |
| Total Liabilities | $31,857 |
| Shareholders' Equity | |
| Common Shares | 1,022 |
| Retained earnings | -70,597 |
| Other shareholders' equity | 41,955 |
| TOTAL | $-27,620 |
| Total Liabilities And Equity | $4,237 |